CPC

Thuốc sát trùng Cần Thơ ·HNX ·2026Q1

▲ Slightly positive

Operating efficiency is improving Net margin 4.51%, +1.08pp YoY
Price
18,200
Latest close
03 Jun 2026
P/E 9.07x
P/B 0.90x
EPS 2,007
BVPS 20,234
ROE 9.5%
ROA 6.9%
Profit Margin 4.5%
Asset Turnover 1.53x
Equity Mult. 1.38x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, CPC has not accelerated revenue, but profitability is improving more visibly — profit is at an all-time high. However, operating cash flow is significantly negative relative to profit — this needs monitoring in coming periods.

TTM REVENUE
VND 182bn
−0.9%YoY
NET MARGIN
4.51%
+1.1ppYoY
TTM NET PROFIT
VND 8bn
+30.4%YoY
CFO / Net Income
-1.80x
negative cash flow vs profit
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 22.4 80.1 15.8 63.5 11.9 83.7 17.0 70.7 18.5 82.5 16.7 72.5
Growth -72% +406% -75% +432% -86% +392% -76% +282% -78% +393% -77%
Net Income 0.9 2.6 0.5 4.2 0.6 0.3 0.5 4.8 0.9 4.0 0.5 4.6
Net Margin 4.05% 3.23% 2.91% 6.68% 5.01% 0.40% 2.93% 6.85% 5.05% 4.81% 3.24% 6.41%

Drivers of CPC's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by lower selling expenses. Supporting and offsetting drivers:

Selling expenses ↓ 4.2bn
Finance costs ↓ 2.1bn
Administrative expenses ↑ 1.3bn
Gross profit ↓ 1.1bn
Other profit ↓ 1.0bn
Financial income ↓ 0.6bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 2.1bn
Finance costs ↓ 0.7bn
Selling expenses ↑ 1.1bn
Financial income ↓ 0.7bn
Administrative expenses ↑ 0.7bn
Tax ↑ 0.1bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 7.3% = 3.4% × 1.52 × 1.41
2026Q1 9.5% = 4.5% × 1.53 × 1.38

ROE rose from 7.3% to 9.5% — mainly driven by net margin, despite leverage moving in the opposite direction.

Net margin: 4.5% +1.1pp Asset turnover: 1.53x +0.01x Leverage: 1.38x -0.03x

Is the profit sustainable?

Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.

very positive positive stable watch under pressure

What is driving the margin?

Net margin edged up to 4.51%, rising 1.1pp. Core operating signals are improving as SG&A / Revenue fell 1.5pp are enough to offset pressure from Gross margin fell 0.4pp (in addition, Net financial result / Revenue rose 0.8pp added support while Other profit / Revenue fell 0.5pp remained a drag).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin 4.51% +1.1pp
Gross Margin 21.55% −0.4pp
SG&A / Revenue 15.69% −1.5pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 1.8 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC expanded to 9.28%, rising 1.7pp. That translates to 9.28 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 1.5pp, with capital turnover fell 0.44x; with invested capital holding roughly steady.

NOPAT margin is driving the improvement — ROIC has cleared the deposit-rate threshold but not yet the typical cost of equity level, and this momentum needs to hold as new invested capital is fully deployed.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 9.28% +1.7pp
NOPAT Margin 4.56% +1.5pp
Capital Turnover 2.03x −0.44x
Average Invested Capital 89.4bn +15.1bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.57x equity, net debt at 0.10x equity.

Inventory ended the period at 27.1bn, roughly 20.1% of total assets.

Over the last 12 months, working capital released 0.0bn of cash.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables were broadly stable → neutral CFO:
Inventories were broadly stable → neutral CFO:
Payables were broadly stable → neutral CFO:

Working Capital Efficiency

Cash conversion cycle lengthened by 1.8 days versus the same period last year. The main moves came from DIO rose 5.5 days, DSO rose 0.9 days, and DPO rose 4.6 days.

Working capital cycle is flat — components are offsetting each other.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 92.3 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +0.9 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 33.5 days +0.9 days
Inventory 78.7 days +5.5 days
Payables 19.8 days +4.6 days
Cash Conversion Cycle 92.3 days +1.8 days

Is financial risk significant?

Leverage is safe but FCF is negative at 16.2bn due to capex of 1.4bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage is balanced for now, with net debt / equity at 0.10x and interest coverage at 2.79x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 45.4% of debt, and total debt stands at 15.5bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity 0.10x +0.11x
Interest Coverage 2.79x +1.59x
Cash / Debt 45.4% −69.1pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI -1.80x −5.56x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

Operating cash flow reached -35.3bn in 2025, against investing cash flow of 18.4bn.

Post-investment cash flow was negative +16.9bn. Financing cash flow was positive +4.6bn.

CFO / net income was -1.80x.

After spending +1.4bn on fixed-asset investment, the business generated trailing free cash flow of −16.2bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 14.8bn −38.3bn
Cash Capex 1.4bn −4.3bn
FCF TTM −16.2bn −34.1bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 1.1 pp. The main risk still sits in self-funded cash generation remains weak.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 4.51% after expanding 1.1pp versus the same period last year.

Key risk: self-funded cash generation remains weak, with trailing-12M FCF still at 16.2bn.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
171.3 190.0 189.4 188.6 189.7
Cost of Goods Sold
131.7 148.5 147.0 155.6 0.0
Gross Profit
39.6 41.5 42.4 33.0 38.1
Financial Expenses
3.7 4.5 4.9 6.3 -3.2
Selling Expenses
15.5 15.1 18.0 13.2 -15.7
General and Administrative Expenses
13.6 12.1 12.5 8.2 -11.3
Operating Profit
11.0 14.1 12.6 12.3 11.9
Profit Before Tax
11.4 15.0 12.8 12.1 11.8
Net Income
9.0 10.0 10.2 9.6 9.6
Profit Attributable to Parent
9.0 10.0 10.2 9.6 9.6
Earnings per Share
2,393.00 2,111.00 2,101.00 2,221.69 2,351.00

Explore Other Stocks In The Same Sector

DCM, DPM, DDV, BFC, VFG, VAF, LAS, NFC, SFG, PCE, VPS, PSE, PMB, PSW, AVG, SPC, DHB, DOC, BT1, HSI, QBS, ABS

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.